Send to

Choose Destination
Obstet Gynecol. 1994 Dec;84(6):1006-9.

The copper T380A intrauterine device in women with type II diabetes mellitus.

Author information

Department of Obstetrics and Gynecology, Los Angeles County+University of Southern California Medical Center, Women and Children's Hospital.



To evaluate the safety and efficacy of the copper T380A intrauterine device (IUD) in women with type II, non-insulin-dependent diabetes mellitus.


From June 1988, 176 women with type II diabetes, in whom the copper T380A IUD was inserted, were followed prospectively until: study closure (June 1993); termination for pregnancy, expulsion, or removal for medical or personal reasons; or termination for loss to follow-up.


Sixteen women never returned after initial insertion, leaving 160 women who were followed a total of 3066 months, with 117 continuing follow-up after their reexamination visit 6-12 weeks after insertion. None developed acute salpingitis. The overall removal rates per 100 woman-years were as follows: for pregnancy, 1.57; for expulsion, 1.96; for discontinuation because of medical reasons (including pain and bleeding), 4.31; and for personal reasons, 3.91. The continuation rate at the end of 3 years after insertion was 70%.


The copper T380A IUD appears to be safe and effective in women with type II diabetes when standard criteria for IUD insertion are followed.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center